Nu Skin Enterprises, Inc. (NYSE:NUS) – Stock analysts at Jefferies Financial Group dropped their FY2018 earnings estimates for Nu Skin Enterprises in a note issued to investors on Wednesday, November 7th, Zacks Investment Research reports. Jefferies Financial Group analyst S. Wissink now expects that the company will post earnings of $3.52 per share for the year, down from their prior forecast of $3.60. Jefferies Financial Group has a “Buy” rating and a $92.00 price objective on the stock. Jefferies Financial Group also issued estimates for Nu Skin Enterprises’ Q4 2018 earnings at $1.05 EPS, Q2 2019 earnings at $1.07 EPS, Q3 2019 earnings at $1.04 EPS and Q4 2019 earnings at $1.09 EPS.
Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Wednesday, November 7th. The company reported $0.94 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.96 by ($0.02). Nu Skin Enterprises had a net margin of 5.93% and a return on equity of 27.50%. The firm had revenue of $675.31 million during the quarter, compared to analyst estimates of $664.99 million. During the same period last year, the business earned $0.76 EPS. The firm’s revenue was up 19.8% compared to the same quarter last year.
Several other brokerages also recently issued reports on NUS. DA Davidson started coverage on shares of Nu Skin Enterprises in a research report on Tuesday, October 9th. They issued a “buy” rating and a $92.00 price objective for the company. Zacks Investment Research downgraded shares of Nu Skin Enterprises from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 8th. Citigroup set a $88.00 price objective on shares of Nu Skin Enterprises and gave the company a “buy” rating in a research report on Thursday, November 8th. Tigress Financial reiterated a “buy” rating on shares of Nu Skin Enterprises in a research note on Wednesday, November 21st. Finally, Bank of America reiterated an “underperform” rating and set a $65.00 target price (down from $75.00) on shares of Nu Skin Enterprises in a research note on Thursday. Two analysts have rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $83.63.
NYSE:NUS traded down $1.04 during trading hours on Monday, hitting $63.79. The stock had a trading volume of 356,907 shares, compared to its average volume of 452,771. The company has a quick ratio of 1.25, a current ratio of 1.93 and a debt-to-equity ratio of 0.44. Nu Skin Enterprises has a 1-year low of $60.60 and a 1-year high of $88.68. The company has a market capitalization of $3.60 billion, a price-to-earnings ratio of 19.75, a price-to-earnings-growth ratio of 1.64 and a beta of 0.99.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Harvest Fund Management Co. Ltd lifted its stake in Nu Skin Enterprises by 162.9% during the third quarter. Harvest Fund Management Co. Ltd now owns 1,291 shares of the company’s stock worth $106,000 after purchasing an additional 800 shares during the last quarter. Global X Management Co LLC lifted its stake in Nu Skin Enterprises by 141.9% in the second quarter. Global X Management Co LLC now owns 1,732 shares of the company’s stock valued at $135,000 after buying an additional 1,016 shares during the last quarter. Ffcm LLC lifted its stake in Nu Skin Enterprises by 181.9% in the third quarter. Ffcm LLC now owns 1,911 shares of the company’s stock valued at $177,000 after buying an additional 1,233 shares during the last quarter. First Hawaiian Bank bought a new stake in Nu Skin Enterprises in the third quarter valued at $165,000. Finally, Advisors Asset Management Inc. lifted its stake in Nu Skin Enterprises by 151.9% in the third quarter. Advisors Asset Management Inc. now owns 2,345 shares of the company’s stock valued at $193,000 after buying an additional 1,414 shares during the last quarter. Hedge funds and other institutional investors own 74.66% of the company’s stock.
In other news, General Counsel D Matthew Dorny sold 2,500 shares of the stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $82.18, for a total transaction of $205,450.00. Following the completion of the transaction, the general counsel now directly owns 33,871 shares in the company, valued at approximately $2,783,518.78. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Over the last quarter, insiders have sold 7,500 shares of company stock valued at $537,625. Company insiders own 5.20% of the company’s stock.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Friday, November 30th will be paid a dividend of $0.365 per share. This represents a $1.46 annualized dividend and a dividend yield of 2.29%. The ex-dividend date of this dividend is Thursday, November 29th. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 45.20%.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Read More: Yield Curve
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.